Table 2 of Oglesby, Mol Vis 2016; 22:82-99.

Table 2. Second experimental group undergoing proteomic analysis: IOP, axial length and axon loss.

Strain Time IOP versus control % axial length Increase % axon loss
CD1 1 week 6.26 + 3.0** 6.1±1.7* 13.71±27.7
6 weeks 5.6 + 3.3** 9.6±4.0* −1.5±4.5
B6 1 week 11.1±7.4** 10.3±0.07** −5.3±9.9
6 weeks 7.7±3.6** 9.1±7.8** 9.5±15.9
Aca23 1 week 5.6±3.7** 3.0 ± 0.03* −1.5±13.9
6 weeks 5.3±4.8** 3.0 ±.04 −10.08±24.0

% axon loss is median compared to pooled controls. IOP is mean difference in IOP compared to untreated fellow eye over the time period. Axial length is compared to individual fellow control eye; n=5 scleras per time point. Data are mean±standard deviation. Minus % axon loss indicates higher number of axons in glaucoma eye than fellow=no damage. *=p<0.05 and **=p<0.01, t test comparing glaucoma to fellow eye control.

Oglesby, Mol Vis 2016; 22:82-99. http://www.molvis.org/molvis/v22/82

©2016 Molecular Vision http://www.molvis.org/molvis/

ISSN 1090-0535